Quantitatively monitoring AIDS policy implementation in China by Liu, Yufen et al.
Quantitatively monitoring AIDS policy
implementation in China
Yufen Liu, Zunyou Wu,* Yurong Mao, Keming Rou, Lu Wang and Fujie Zhang
National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
*Corresponding author. National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention,
155 Changbai Road, Changping District, Beijing 102206, China. E-mail: wuzy@263.net; wuzunyou@chinaaids.cn
Accepted 17 May 2010
Background China has been scaling up its national AIDS programs since 2004.
We tested a hypothesis that incrementally setting realistic quanti-
tative targets for key indicators and monitoring performance would
facilitate AIDS policy implementation in China.
Methods Core indicators monitoring the national AIDS program were de-
veloped, modified and used from 2007 through 2009. Targets of
core indicators were set incrementally and monitored annually.
Data were collected and reported from local counties in all 31 prov-
inces of mainland China. Changes of core indicators from 2007 to
2009 were calculated and compared using Cochran–Armitage Trend
tests.
Results The number of patients receiving free anti-retroviral treatment and
methadone maintenance treatment increased from 41777 to 81739,
from 97554 to 241975, respectively, between 2007 and 2009. The
proportion of newly reported HIV/AIDS cases with a completed epi-
demiological investigation increased from 77.7% in 2007 to 91.1% in
2009 (P<0.0001). The proportion of spouses of newly reported
HIV/AIDS cases being tested for HIV increased from 24.7 to 63.4%
(P<0.001). Follow-up visits to people with HIV and AIDS increased
from 32.8 and 34.0% in 2007 to 74.6 and 78.5% in 2009, respectively
(both P<0.0001). The proportion of CD4
þ cell count monitoring for
people with HIV and AIDS increased from 45.3 and 10.1% in 2007
to 54.2 and 62.5% in 2009, respectively (both P<0.001). Viral load
monitoring for AIDS patients receiving anti-retroviral treatment
increased from 9.1 to 48.5% (P<0.001).
Conclusions Setting targets for core indicators and monitoring performance has
facilitated implementation of the national AIDS program in China.
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ii90Introduction
China reported its first AIDS case in 1985,
1 and
experienced a rapid increase in the number of cases
of HIV/AIDS since 1995.
2 Since 2004, the Chinese gov-
ernment has put AIDS at the top of the public health
agenda and has significantly increased financial sup-
port for implementation of the national HIV/AIDS
programs.
3–5 In 2006, specific targets were set to
assess the impact and delivery of this increased
government support.
6 These included targets for
increasing the level of HIV/AIDS knowledge among
urban and rural residents to 75 and 65%, respective-
ly, by 2007, and to 85 and 75%, respectively, by
2010; to ensure primary prevention measures reached
70% of high-risk groups by 2007 and 90% by 2010;
and to ensure that free anti-retroviral treatment
reached 50% of patients who needed it by 2007 and
80% by 2010.
6
In order to promote and monitor the implementa-
tion of the national AIDS programs, the National
Center for AIDS/STD Control and Prevention
(NCAIDS) at the Chinese Center for Disease Control
and Prevention (China CDC) piloted setting annual
goals in 2006. The first two indicators used were to
open 300 community-based methadone maintenance
treatment clinics and to have enrolled at least 30000
patients (cumulative) in the national free anti-
retroviral treatment program by the end of 2006.
Both these targets were achieved, which convinced
authorities that setting such targets and collecting
data from each site could effectively promote the na-
tional methadone and anti-retroviral treatment pro-
grams. Therefore, since 2007, the NCAIDS began to
set annual targets to monitor the implementation of
core elements of the national AIDS programs. Core
indicators included HIV testing, epidemiological in-
vestigation for newly identified HIV/AIDS cases,
follow-up visits for individuals infected with HIV/
AIDS, monitoring CD4
þ cell counts, condom promo-
tion for high-risk groups such as female sex workers
and men who have sex with men, the number of
methadone clinics and the number of drug users
served by the methadone program and the number
of patients receiving anti-retroviral treatment.
Program directors hypothesized that incrementally
setting realistic quantitative targets and monitoring
performance to hold implementers accountable
would facilitate implementation of national AIDS pro-
gram. This article provides a summary of how key
indicators for monitoring implementation of the na-




The first step in developing the quantitative monitor-
ing system was selection of core indicators. Indictors
had to assess the national AIDS program’s impact on
the rate of HIV infection, primary prevention, treat-
ment and care. Indictors had to be meaningful, prag-
matic and able to objectively measure quality of
implementation. Selection of core indicators for moni-
toring implementation was based on a systematic
review of the framework for monitoring and evalu-
ation China’s national AIDS program,
7 indicators
used in UNGASS reporting,
8 indicators used in
Global Fund program
9 and indicators used in assessing
universal access.
10 For pragmatism, meaningfulness
and sustainability, the indicators selected and used
were among those that could be directly retrieved
from the existing data collection system, i.e. China’s
Comprehensive AIDS Data System, described in detail
by Mao and colleagues in this issue.
11
Twelve core indicators were used in 2007 (Table 1),
including: (i) proportion of newly reported HIV/AIDS
cases being investigated epidemiologically; (ii) propor-
tion of newly identified HIV/AIDS cases being
reported in a timely manner via the Internet; (iii) pro-
portion of people living with HIV (not including
AIDS) who received regular visits by public health
workers and intervention at least once a year;
(iv) proportion of people living with HIV (not includ-
ing AIDS) whose CD4
þ cell counts were monitored at
least once a year to determine if they needed ART;
(v) the total number of patients who have received
anti-retroviral treatment; (vi) the total number of pa-
tients currently receiving anti-retroviral treatment;
(vii) the proportion of patients who survived for
12 months and remained in treatment after initiation
of anti-retroviral treatment; (viii) the proportion of
children with AIDS receiving anti-retroviral treat-
ment; (ix) the total number of drug users who have
received methadone maintenance treatment; (x) the
total number of drug users currently receiving metha-
done maintenance treatment; (xi) the annual reten-
tion rate of drug users in methadone maintenance
treatment; and (xii) proportion of sex workers receiv-
ing HIV/STD intervention measures, including
condom promotion and sexual health education.
Review of performance was conducted on an annual
basis and feedback was collected for improvement.
Core indicators used in 2007–09 are shown in
Table 1. Twelve indicators were used in 2007, 19 in
2008 and 16 in 2009 and 10 indictors were used con-
sistently from 2007 through 2009.
Between 2007 and 2009, few indictors were removed
and a few were added:
(i) timely case reporting via the Internet was used
in 2007 and 2008 but not in 2009 since it
reached 100% in 2008 and thus had no room
to improve;
(ii) the proportion of subjects who were screened as
HIV positive and were notified and offered
counselling was added in 2008 and removed
in 2009, since data available for this indicator
were from voluntary counselling and testing
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one-quarter of reported cases;
(iii) the proportion of children with AIDS receiving
anti-retroviral treatment was used in 2007 only
and removed in 2008 and 2009 since there were
already other indicators of treatment;
(iv) the proportion of anti-retroviral treatment-
naı ¨ve patients who had achieved viral suppres-
sion (viral load <1000 copies/ml) during the
first 6–12 months of treatment was added in
2008 and removed in 2009 since the proportion
of the patients receiving viral load testing is still
rather low, so this indicator cannot reflect the
real proportion of patients whose virus has
been inhibited;
(v) the HIV antibody-testing rate for the spouse/
regular sex partner of people living with
HIV/AIDS was added in 2008. In 2009, it was
divided into rates for newly reported cases and
existing cases. The purpose of this indicator was
to help reduce secondary transmission of HIV
by offering testing, regular visits by public
health workers and providing referrals for
other services;
(vi) the proportion of men who have sex with
men receiving intervention activities was
added in 2008 and 2009, since the HIV
infection rate in this group was steadily
rising and has become a focus for the overall
prevention of HIV/AIDS. The intervention
activities included public health out-reach
activities for safer sex counselling, condom
promotion, HIV testing and other referral
services.
Table 1 Selection of core indicators for monitoring AIDS policy implementation in China, 2007–2009
Core indicators 2007 2008 2009
Proportion of newly identified HIV/AIDS cases who have been investigated
epidemiologically
333
Proportion of newly identified HIV/AIDS cases being reported in a time manner via the
Internet
33–
Proportion of newly screened HIV-antibody-positive cases being notified and counselled
based on first screening test result in a timely manner (not wait for confirmation)
– 3 –
Proportion of people living with HIV (not including AIDS) who received regular visits by
public health workers and intervention at least once per year
333
Proportion of spouse/regular sex partners of newly reported HIV/AIDS cases tested for HIV
antibody
– 33
Proportion of spouse/regular sex partners of previously reported HIV/AIDS cases tested for
HIV antibody
– 33
Proportion of people living with AIDS who received regular visits by public health workers
and intervention at least once
– 33
Proportion of people living with HIV (not AIDS) whose CD4
þ cell counts were monitored
at least once a year, to determine anti-retroviral therapy eligibility
333
Proportion of patients receiving anti-retroviral treatment monitored for CD4
þ cell count at
least once a year to determine treatment effectiveness
– 33
Total number of the patients who have received anti-retroviral treatment 333
Total number of the patients currently receiving anti-retroviral treatment 333
Proportion of patients on anti-retroviral treatment who survived and remained in
treatment for 12 months
333
Proportion of children with AIDS receiving anti-retroviral treatment 3 ––
Proportion of patients receiving anti-retroviral treatment who have been monitored for
viral load at least once a year to monitor treatment failure
– 33
Proportion of anti-retroviral treatment-naı ¨ve patients whose viral load has been inhibited
during the first 6–12 months of treatment
– 3 –
Total number of patients who have received methadone maintenance treatment 333
Total number of patients currently receiving methadone maintenance treatment 333
Annual retention rate of drug users in methadone maintenance treatment 333
Proportion of sex workers receiving HIV/STD intervention measures 333
Proportion of men who have sex with men receiving intervention measures – 33
In the table, 3 means the indicator was used in that year.
ii92 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYOther important indicators for which data were col-
lected included outreach intervention activities cover-
ing female sex workers per month and reaching men
who have sex with men per month, and needle ex-
change program reaching injecting drug users.
However, the interpretation of these data should be
cautious because it is difficult to estimate the size of
the target population.
Setting targets
Setting meaningful targets was very important and
required the consideration of several factors. First,
the 2006–10 5-year action plan had set targets for
specific measures to be accomplished by 2007 and
by 2010, respectively.
6 Secondly, indicators needed
to balance public health significance but had to be
achievable. Targets were set based on previous year’s
performance and a reasonable incremental improve-
ment. Specific quantitative targets selected are given
in Table 2.
Accountability
Two strategies were used for accountability and for
monitoring implementation. First, the directors of
each technical division at the NCAIDS/China CDC
were held accountable for indicators that fell within
their portfolio. Each March, a contract was drawn
containing specific indicators and targets for each div-
ision, which was signed by both the director of
the NCAIDS and the directors of each division. At
the end of December, an external review panel was
invited to assess the performance of each division ac-
cording to their targets. An annual performance
evaluation meeting was held during which division
directors reported on their progress for all relevant
indicators.
Secondly, accountability for achieving each specific
indicator was assigned to each local province. Each
January, a national annual AIDS meeting has been
held to review the past year’s performance and to
set new targets for the current year. Progress towards
each indicator for each province is calculated and
then ranked. Provinces that ranked in the top five
were awarded a National AIDS Program Quality
Performance medal. Provinces ranked at the bottom
were reminded to work hard and to improve their
performance in the following year.
Data collection and analysis
All original data were collected routinely by local im-
plementers in 31 provinces and were entered into the
Chinese Comprehensive HIV/AIDS Data Management
System (a detailed description can be found in the
article by Mao and colleagues, in this issue).
11 Data
were retrieved from the database for 2007–09 and
evaluated. Annual values of each core indicator were
calculated and compared with set targets. The
Cochran–Armitage Trend Test was used to test if
performances improved over time.
Results
Between 2007 and 2009, the availability of the nation-
al free anti-retroviral treatment program increased
from 1190 counties to 1821. The cumulative number
of AIDS patients who ever received free anti-retroviral
treatment increased from 41777 in 2007 to 58795 in
2008 and to 81739 in 2009, and the number of pa-
tients who remained in treatment increased from
32849 in 2007 to 48254 in 2008 and to 65481 in
2009. The national methadone maintenance treatment
program expanded from 503 clinics in 2007 to 600
clinics in 2008 and to 680 clinics in 2009. The cumu-
lative number of drug users who had ever enrolled in
the program increased from 97554 in 2007 to 178684
in 2008 and to 241975 in 2009, and the number of
drug users who remained in treatment increased from
61557 in 2007 to 93997 in 2008 and to 112831 in
2009. The average number of drug users remaining in
treatment per clinic increased from 122/clinic in 2007
to 156/clinic in 2008 and to 166/clinic in 2009. The
number of needle exchange sites increased from
879 in 2008, to 962 in 2009, and the number of
injecting drug users using the service monthly
increased from 36084 in 2008 to 39075 in 2009.
Monthly outreach intervention activities for female
sex workers increased from 329179 per month in
2008 to 418975 per month in 2009. These activities
reaching men who have sex with men increased from
49062 per month in 2008 to 85727 per month
in 2009.
Core indicators used for monitoring implementation
from 2007 through 2009 are presented in Table 2. The
proportion of newly reported HIV/AIDS cases that had
been investigated increased from 77.7% in 2007 to
91.1% in 2009 (P<0.001). The proportion of spouses
of newly reported HIV/AIDS being tested for HIV
increased from 24.7% in 2007 to 63.4% in 2009
(P<0.001). The proportion of spouses of previously
reported HIV/AIDS cases who had not been tested
or had tested negative being tested for HIV increased
from 48.3% in 2007 to 53.5% in 2009 (P<0.001). The
follow-up rate for continuing services for people with
HIV increased from 32.8% in 2007 to 74.6% in 2009,
and the follow-up rate for continuing intervention
services for AIDS patients increased from 34.0% in
2007 to 78.5% in 2009. The proportion of CD4
þ
cell-count monitoring for people with HIV increased
from 45.3% in 2007 to 54.2% in 2009, and for people
with AIDS increased from 10.1% in 2007 to 62.5% in
2009. The proportion of AIDS patients in the
anti-retroviral treatment program who had their
viral load monitored at least once per year increased
from 9.1% in 2007 to 48.5% in 2009. The proportion
of patients starting anti-retroviral treatment who
AIDS POLICY IMPLEMENTATION ii93remained in the treatment program for at least 1 year
was roughly stable for the years 2007–09, at 82.3
 84.4%. The annual retention rate for drug users in
the methadone program decreased from 71.7% in
2007 to 65.2% in 2009.
Discussion
Progress has been made in achieving the goals of the
Chinese national AIDS program in recent years.
Although political and financial commitment has
Table 2 Evaluation of core indicators used for monitoring AIDS policy implementation in China from 2007 through 2009
Indicators
2007 2008 2009
P-value Target Achieved Target Achieved Target Achieved
Proportion of newly reported HIV/AIDS cases who
have been investigated epidemiologically (%)
70 77.7 75 81.1 75 91.1 <0.0001
Proportion of spouses/regular sex partners of newly
reported HIV/AIDS cases tested for HIV antibody
(%)
NT 24.7 50 55.1 60 63.4 <0.0001
Proportion of spouses/regular sex partners of previ-
ously reported HIV/AIDS (41 year ago) cases tested
for HIV antibody (%)
NT 48.3 50 45.4 50 53.5 0.02
Proportion of all people living with HIV (not AIDS)
who have received regular visit by public health
workers and intervention at least once a year (%)
50 32.8 70 55.7 70 74.6 <0.0001
Proportion of all people living with AIDS who have
received regular visits by public health workers and
intervention at least once a year (%)
NT 34.0 70 63.6 70 78.5 <.0001
Proportion of people living with HIV (not AIDS) who
have had their CD4
þ cell count monitored at least
once a year to determine ART eligibility (%)
NT 45.3 50 48.4 50 54.2 <0.0001
Proportion of patients receiving anti-retroviral treat-
ment monitored for CD4
þ cell count at least once a
year to determine treatment effectiveness (%)
NT 10.1 50 39.5 50 62.5 <0.0001
Total number of patients who have received
anti-retroviral treatment
36000 41777 46000 58795 60000 81739
Total number of patients currently receiving
anti-retroviral treatment
28800 32498 36800 48254 48000 65481
Proportion of patients on anti-retroviral treatment
who survived and remained in treatment for
12 months (%)
80 83.6 80 84.4 80 82.3 40.05
Proportion of patients receiving anti-retroviral treat-
ment who have been monitored for viral load at
least once a year to monitor treatment failure (%)
NT 9.1 NT 19.3 50 48.5 <0.0001
Total number of methadone maintenance treatment
sites
500 503 657 602 705 680 <0.001
Total cumulative number of the patients who have
received methadone maintenance treatment
66000 97554 115700 178684 136200 241975
Total number of the patients currently receiving
methadone maintenance treatment
46200 61557 75205 93997 88530 112831
Annual retention rate of drug users in methadone
maintenance treatment for 12 months (%)
70 71.7 65 69.5 65 65.2 0.0017
Average number of drug users receiving methadone
maintenance treatment per clinic
150 122 150 156 150 166
Proportion of sex workers receiving HIV/STD
intervention measures (%)
70 78.4 70 91.4 70 74.3 40.05
Proportion of men who have sex with men receiving
intervention measures (%)
NT 74.3 50 83.9 80 75.4 40.05
NT¼no target was set.
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tive monitoring of the nation-wide implementation of
the program by the NCAIDS has played a crucial role.
The unified web-based national AIDS data system
makes this quantitative monitoring feasible and
timely (detailed information can be found in the art-
icle by Dr Mao and her colleagues, in the issue).
11
This quantitative monitoring approach was initially
met with great resistance from both technical div-
isions of the NCAIDS/China CDC and local imple-
menters since these specific measurable targets hold
them accountable and responsible. The pilot of two
indicators in 2006 helped to develop meaningful and
acceptable indicators and targets for 2007–09.
Observable increases in coverage encouraged both
central and local public health officials to continue
this monitoring strategy.
Continuing review and refinement of indicators and
targets has helped implementers to understand core
elements of the national AIDS program. All core
indicators covered critical measures to identify
HIV-infected individuals, to reduce secondary trans-
mission of HIV to sexual and needle sharing partners,
and to reduce deaths caused by AIDS. It is believed
that continuing this exercise will have a positive
impact on controlling the HIV/AIDS epidemic in
China.
Although progress has been made and coverage has
increased, coverage still often falls below targets and
may be insufficient to prevent the further spread of
HIV or to significantly reduce mortality from AIDS.
Estimations made in 2005, 2007 and 2009
4,12,13 sug-
gested that the number of new HIV infections
reduced from 70000 per year in 2005 to 50000 per
year in 2007, and further to 48000 per year in 2009,
but the number of people living with HIV/AIDS
increased from 650000 in 2005 to 700000 in
2007 and to 740000 in 2009. While the number of
patients covered by the national free anti-retroviral
treatment has increased each year, the number of
deaths among people living with AIDS has also
increased: from 5544 in 2007 to 9748 in 2008 and
to 12287 in 2009.
Quantitative performance monitoring is focused on
the process of implementation. In the early stages,
particularly when the indicators values were low, sig-
nificant change or improvement could be easily
achieved and feedback was encouraging, motivating
health officials at central and local levels to work
hard. As the value of these core indicators becomes
elevated, an incremental change or improvement
will be less. Thus, maintaining the momentum will
become more difficult. The monitoring system will
need to shift focus to maintain good coverage and
to ensure the quality of programmes is high. For
example, patients on ART are currently monitored
annually for CD4
þ, but a shorter interval may be
required to prevent the adverse consequences of treat-
ment failure.
14
In summary, remarkable improvements have been
observed in the implementation of the national
AIDS program in China from 2007 to 2009. The strat-
egy of setting targets and making local implementers
accountable and monitoring core indicators has facili-
tated the implementation of the national AIDS pro-
gram in China.
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KEY MESSAGES
  China’s national HIV/AIDS prevention, treatment and care programs have significantly improved in
the past 3 years.
  Setting annual targets for core indicators and monitoring performance that hold implementers
accountable has facilitated implementation of the national AIDS program in China.
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